Merck & Co., Inc., Schering-Plough Corporation Delay Earnings for Vytorin Update
NEW YORK, July 21 (Reuters) - Merck & Co and Schering-Plough said they would delay release of company earnings until after the stock market closes on Monday, in order to update investors on a new important study of their shared Vytorin cholesterol fighter.